Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Feigin

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Human Brain Mapping|June 18, 2003
Learning networks in health and Parkinson's disease: reproducibility and treatment effectsMaren Carbon, Maria Felice Ghilardi, Andrew Feigin, et al.
Annals of Neurology|November 2, 2005
Preclinical Huntington's disease: compensatory brain responses during learningAndrew Feigin, Maria-Felice Ghilardi, Chaorui Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonismAndrew Feigin, Angelo Antonini, Masafumi Fukuda, et al.
The Journal of Clinical Investigation|July 19, 2014
Network modulation following sham surgery in Parkinson's diseaseJi Hyun Ko, Andrew Feigin, Paul J Mattis, et al.
Neurourology and Urodynamics|May 17, 2018
Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's diseaseGregory Vurture, Benoit Peyronnet, Andrew Feigin, et al.
The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.
Neurology|January 24, 2014
Abnormal metabolic network activity in REM sleep behavior disorderFlorian Holtbernd, Jean-François Gagnon, Ron B Postuma, et al.
Science Translational Medicine|November 30, 2018
Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivityMartin Niethammer, Chris C Tang, An Vo, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
The Journal of Clinical Investigation|August 30, 2013
Metabolic network as a progression biomarker of premanifest Huntington's diseaseChris C Tang, Andrew Feigin, Yilong Ma, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Human Brain Mapping|June 18, 2003
Learning networks in health and Parkinson's disease: reproducibility and treatment effectsMaren Carbon, Maria Felice Ghilardi, Andrew Feigin, et al.
Annals of Neurology|November 2, 2005
Preclinical Huntington's disease: compensatory brain responses during learningAndrew Feigin, Maria-Felice Ghilardi, Chaorui Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonismAndrew Feigin, Angelo Antonini, Masafumi Fukuda, et al.
The Journal of Clinical Investigation|July 19, 2014
Network modulation following sham surgery in Parkinson's diseaseJi Hyun Ko, Andrew Feigin, Paul J Mattis, et al.
Neurourology and Urodynamics|May 17, 2018
Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's diseaseGregory Vurture, Benoit Peyronnet, Andrew Feigin, et al.
The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.
Neurology|January 24, 2014
Abnormal metabolic network activity in REM sleep behavior disorderFlorian Holtbernd, Jean-François Gagnon, Ron B Postuma, et al.
Science Translational Medicine|November 30, 2018
Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivityMartin Niethammer, Chris C Tang, An Vo, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
The Journal of Clinical Investigation|August 30, 2013
Metabolic network as a progression biomarker of premanifest Huntington's diseaseChris C Tang, Andrew Feigin, Yilong Ma, et al.
Pageof 7